ProQR Therapeutics
PRQR
#8654
Rank
ยฃ0.13 B
Marketcap
ยฃ1.32
Share price
8.33%
Change (1 day)
28.21%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for ProQR Therapeutics CIK: 0001612940
The 20-F is a 10-K equivalent for non-US companies, as a foreight company ProQR Therapeutics only files 20-F reports

Thumbnail ProQR Therapeutics 20-F Annual Report 2025

20-F Annual Report 2025

Language: English

View Annual Report (20-F)
Thumbnail ProQR Therapeutics 20-F Annual Report 2024

20-F Annual Report 2024

Language: English

View Annual Report (20-F)
Thumbnail ProQR Therapeutics 20-F Annual Report 2023

20-F Annual Report 2023

Language: English

View Annual Report (20-F)
Thumbnail ProQR Therapeutics 20-F Annual Report 2022

20-F Annual Report 2022

Language: English

View Annual Report (20-F)
Thumbnail ProQR Therapeutics 20-F Annual Report 2021

20-F Annual Report 2021

Language: English

View Annual Report (20-F)
Thumbnail ProQR Therapeutics 20-F Annual Report 2020

20-F Annual Report 2020

Language: English

View Annual Report (20-F)
Thumbnail ProQR Therapeutics 20-F Annual Report 2019

20-F Annual Report 2019

Language: English

View Annual Report (20-F)
Thumbnail ProQR Therapeutics 20-F Annual Report 2018

20-F Annual Report 2018

Language: English

View Annual Report (20-F)
Thumbnail ProQR Therapeutics 20-F Annual Report 2017

20-F Annual Report 2017

Language: English

View Annual Report (20-F)
Thumbnail ProQR Therapeutics 20-F Annual Report

20-F Annual Report 2017-03-31

Language: English

View Annual Report (20-F)
Thumbnail ProQR Therapeutics 20-F Annual Report

20-F Annual Report 2016-03-31

Language: English

View Annual Report (20-F)
Thumbnail ProQR Therapeutics 20-F Annual Report

20-F Annual Report 2015-04-22

Language: English

View Annual Report (20-F)